期刊文献+

胺碘酮与西地兰治疗快速型心房纤颤疗效比较 被引量:2

下载PDF
导出
摘要 目的:观察井比较胺碘酮与西地兰治疗快速型心房纤颤的疗效。方法:选择本院2015—2016年快速型心房纤颤患者42例,随机分为胺碘嗣组和西地兰组各21例,两组患者在常规抗心哀基础上,分别加用胺碘酮、西地兰静脉注射,观察两组患者治疗24h后房颤转复率、心室率、心功能改善情况及不良反应。结果:胺碘酮组房颤疗效显效13例(61.9%),有效6例(28.5%),总有效率905%。西地兰组显放8例(38.1%),有效6例(28.6%),总有效率66.7%。而胺碘酮组心功能改善总有效率为85.7%,西地兰组总有效率为61.9%。两组比较胺碘酮组在转复房颤优于西地兰。结论:静脉应用胺碘酮治疗快速型心房纤颤较静脉应用西地兰更迅速、有效,因此,胺碘酮可作为处理快速型心房纤颤的理想药物。 Objective :To observe and compare the amiodarone and west to the curative effect of treatment of fast atrial fibrillation (af). Methods: our hospital in 2015-2016 type fast 42 patients with atrial fibrillation, were randomly divided into amiodarone group and west to LAN all 21 cases, two groups of patients on the basis of conventional heart failure, combined with amiodarone, west to intravenous injection, observe two groups of 24 h after treatment in patients with atrial fibrillation converting rate, ventricular rate, improve heart function, and adverse reactions. Results: atrial fibrillation effect of amiodarone group 13 cases were markedly improved (61.9%), effective 6 cases (28.5%), the total effective rate was 90.5%. Sildenafil orchid group, 8 cases were markedly improved (38.1%), effective 6 cases (28.6%), the total effective rate was 66.7%. Cardiac function improvement and amiodarone group total effective rate was 85.7%, west to group the total effective rate was 61.9%. Two groups to compare amiodarone group in converting atrial fibrillation is superior to the west. Conclusion: intravenous application of amiodarone treatment of fast atrial fibrillation with intravenous application more quickly and efficiently, thus, amine ketone of iodine can be used as an ideal drug treatment of fast atrial fibrillation (af).
出处 《国际心血管病杂志》 2017年第A01期152-153,共2页 International Journal of Cardiovascular Disease
关键词 胺碘酮 西地兰 快速型心房纤颤 amiodarone West to balaam Type fast atrial fibrillation
  • 相关文献

参考文献3

二级参考文献48

  • 1郭林妮,黄元铸,蒋文平,李庚山,陆再英,戚文航,任自文,吴宁,向晋涛,朱俊,方圻,高润霖.胺碘酮抗心律失常治疗应用指南[J].中国心脏起搏与心电生理杂志,2004,18(6):401-407. 被引量:392
  • 2Greene HL,Roden DM,Katz RJ,Woosley RL,Salerno DM,Henthorn RW.The Cardiac Arrhythmia Suppression Trial:first CAST then CAST II[J].J Am Coll Carciol,1992,19∶894-898.
  • 3Podrid PJ.Amiodarone:reevaluation of an old drug[J].Ann Intern Med,1995,122∶689-700.
  • 4Roden DM.Pharmacokinetics of amiodarone:implications for drug therapy[J].Am J Cardiol,1993,72∶45F-50F.
  • 5Singh BN,Venkatesh N,Nademanee K,et al.The historical development,cellular electrophysiology,and pharmacology of amiodarone[J].Prog Cardovasc D S,1989,31∶249-280.
  • 6Singh BN,Nademanee K.Amiodarone and thyroid function:clirical implications during antiarrhythmic therapy[J].Am Heart J,1983,106∶857-869.
  • 7Nattle S.Comparative mechanisms of action of antiarrhythmic drugs[J].Am J Cardiol,1993,72(16)∶13F-17F.
  • 8The CASCADE investigators:The Cascade study-randomized anti-arrhythmic drug therapy in survivors of cardiac arrest in Seattle[J].Am J Cardiol,1993,13∶442-449.
  • 9Levine JH,Massumi A,Scheinman MM,et al.Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias.The Intravenous Amiodarone Multicenter Trial Group[J].J Am Coll Cardiol,1996,27∶67-75.
  • 10Kowey PR,Levine JH,Herre JM,et al.Randomized,double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent,hemodynamically destabilizing ventricular tachycardia or fibrillation.The Intravenous Amiodarone Multicenter Investigators Group[J].Circulation,1995,92∶3255-3263.

共引文献142

同被引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部